Explore Company News Direct From Our Network
Global News from Our Network.
Search and filter the results by company or location to find the news that matters to you.
If you would like to publish news on behalf of your company, please register with us at the following link https://www.pharmaservicesdirectory.com/register
Save
This Search |
View as Grid
| Order by Recently Added
| Order
by Company Name
- Total Results: 1,401
- Total Pages: 176
PharmaEssentia to Establish a Manufacturing Subsidiary in Puerto Rico
PharmaEssentia Corporation, a global biopharmaceutical company headquartered in Taiwan, will invest approximately $46 million to establish a new, wholly owned manufacturing subsidiary in Puerto Rico. The planned investment supports the company’s global manufacturing expansion strategy and is intended to serve as a future manufacturing center for the U.S. market and long-term global demand for BESREMi (ropeginterferon alfa-2b). The investment reflects sustained global demand growth for BESREMi, particularly in the United States, as well as the potential additional demand…
Read more on this story »
Partner Profile
Charles River and Synthace announce partnership for assay development
The collaboration follows a successful proof-of-concept project in which Charles River used Synthace’s software to rapidly develop a 1536-well assay and complete an assay transfer. The project implemented a design of over 700 experimental conditions across multiple laboratories and equipment, demonstrating the software’s ability to handle complex workflows.
View original story »
Partner Profile
Lilly to acquire Orna Therapeutics to advance cell therapies
INDIANAPOLIS and WATERTOWN, Mass., Feb. 9, 2026 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and Orna Therapeutics, Inc., a biotechnology company dedicated to engineering immune cells in vivo, today announced entry into a definitive agreement for Lilly to acquire Orna. Orna is advancing a new class of therapeutics utilizing engineered circular RNA paired with novel lipid nanoparticles to allow the patient’s own body to generate cell therapies that can treat underlying disease. Orna’s lead program is ORN-252, a clinical trial-ready,…
Read more on this story »
Partner Profile
Innovent Biologics and Eli Lilly have entered into a global strategic collaboration
Under the terms of the strategic collaboration, Innovent is expected to lead programs from discovery through clinical proof of concept in China, leveraging its antibody technology platforms and clinical development capabilities.2 As part of the collaboration, Lilly will receive exclusive rights to develop and commercialize the resulting medicines worldwide outside of Greater China, while Innovent retains rights within the region. Innovent is set to receive a $350 million upfront payment and will be eligible for…
Read more on this story »
Partner Profile
Gedeon Richter and Fuji Pharma expand collaboration
Hungary’s largest drugmaker Gedeon Richter (RICHT: HB) and Japan’s Fuji Pharma (TYO: 4554) are significantly strengthening their strategic alliance. Both companies are thus consolidating their position in a market segment that is considered under-served globally, namely women’s healthcare (WHC).
View original story »
Partner Profile
OXB Signs New Multi-Year Commercial Supply Agreement with Bristol Myers Squibb
Oxford, UK – 4 February 2026: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces it has expanded its strategic partnership with Bristol Myers Squibb (“BMS”) (NYSE: BMY), signing a new Commercial Supply Agreement (CSA) for the manufacture and supply of lentiviral vectors for BMS’ CAR-T programmes. This expanded partnership builds on the existing relationship with Bristol Myers Squibb, originally announced in March…
Read more on this story »
Partner Profile
SanegeneBio Enters $1.5 Billion Exclusive Global License Agreement with Genentech for RNAi Program
SanegeneBio and Genentech entered a global licensing agreement aimed at advancing an RNA interference (RNAi) therapeutic program, underscoring continued pharmaceutical interest in genetic medicines that can be scaled beyond rare diseases.
View original story »
Partner Profile
Valneva and Instituto Butantan Announce Initiation of a Pilot Vaccination Campaign in Brazil
Lyon (France), Sao Paulo, (Brazil), February 3, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company and Instituto Butantan, one of the world’s largest biomedical research centers, today announced the initiation of a Pilot Vaccination Strategy (PVS) in Brazil using Valneva’s single-shot chikungunya vaccine, IXCHIQ®. The pilot vaccination program will serve as the basis for post-marketing…
Read more on this story »
Partner Profile
- Total Results: 1,401
- Total Pages: 176
Network News
Keeping the latest and up-to-date news on our companies is a key activity of the editorial team.
We support companies directly through the profiles to allow them update their profile with the latest news and company announcements. Search fields are provided so that you can access news by company name, sector e.g research, manufacturing, equipment, packaging or geography.
The global news is updated daily and its aim is to provide you as a directory user with the information needed to make good buying or supply choices. News covers companies operating within the pharmaceutical, biotechnology, medical device and nutraceutical sectors.
Also through our software applications you can evaluate, rate and score news and company announcements to support corporate risk management activities. Through the software applications it is possible to supplement and add your own news items, keeping a library of news activities on any company identified through the directory.
Take the Next Step
Should you have any questions or require further information please contact us ...
Contact the support team »
Check if your company is listed and claim your online profile ...
Search for your company listing »
If you're not listed in the directory and you want to build a public profile, register for an account ...
Register for an account to build a profile »
Apply for a free trial of our Supplier Management Software ...
Register for an account to trial the software »
